{"product_id":"micardis-telmisartan-80mg-28tab","title":"MICARDIS (TELMISARTAN) 80 MG 28 TAB","description":"\u003cdiv\u003e\n\u003cp data-start=\"0\" data-end=\"39\"\u003e\u003cstrong data-start=\"0\" data-end=\"39\"\u003eMICARDIS (TELMISARTÁN) 80 mg 28 TAB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"41\" data-end=\"234\"\u003e\u003cstrong data-start=\"41\" data-end=\"58\"\u003eComparable a:\u003c\/strong\u003e Telmisartán genérico\u003cbr data-start=\"79\" data-end=\"82\"\u003e\u003cstrong data-start=\"82\" data-end=\"103\"\u003eSustancia activa:\u003c\/strong\u003e Telmisartán\u003cbr data-start=\"115\" data-end=\"118\"\u003e\u003cstrong data-start=\"118\" data-end=\"136\"\u003eConcentración:\u003c\/strong\u003e 80 mg\u003cbr data-start=\"142\" data-end=\"145\" data-is-only-node=\"\"\u003e\u003cstrong data-start=\"145\" data-end=\"162\"\u003ePresentación:\u003c\/strong\u003e Tabletas\u003cbr data-start=\"171\" data-end=\"174\"\u003e\u003cstrong data-start=\"174\" data-end=\"190\"\u003eLaboratorio:\u003c\/strong\u003e Boehringer Ingelheim\u003cbr data-start=\"211\" data-end=\"214\"\u003e\u003cstrong data-start=\"214\" data-end=\"225\"\u003eOrigen:\u003c\/strong\u003e México\u003c\/p\u003e\n\u003cp data-start=\"236\" data-end=\"728\"\u003eEste medicamento se utiliza principalmente para el \u003cstrong data-start=\"287\" data-end=\"330\"\u003etratamiento de la hipertensión arterial\u003c\/strong\u003e (presión alta). El telmisartán es un \u003cstrong data-start=\"368\" data-end=\"429\"\u003eantagonista de los receptores de angiotensina II (ARA-II)\u003c\/strong\u003e que actúa relajando y ensanchando los vasos sanguíneos, lo que ayuda a reducir la presión arterial y disminuir la carga de trabajo del corazón. También puede ser utilizado para reducir el riesgo de eventos cardiovasculares en pacientes con factores de riesgo seleccionados, según indicación médica.\u003c\/p\u003e\n\u003cp data-start=\"730\" data-end=\"882\"\u003eEl consumo de este producto es responsabilidad de quien lo recomienda y de quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"__shopify_paste\" style=\"position: absolute; display: block; left: -1000px; top: 0px; width: 1px; height: 1px; overflow-x: hidden; overflow-y: hidden;\"\u003e\n\u003cdiv dir=\"ltr\" style=\"font-family: arial; font-size: 12px; zoom: 1;\"\u003e\u003cspan class=\"\" lang=\"en\" id=\"result_box\"\u003e\u003cspan title=\"\"\u003eTHERAPEUTIC INDICATIONS: * MICARDIS (telmisartan) is indicated for the treatment of essential hypertension.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eCONTRAINDICATIONS: Hypersensitivity to any of the ingredients. \u003c\/span\u003e\u003cspan title=\"\"\u003eDuring pregnancy and lactation. \u003c\/span\u003e\u003cspan title=\"\"\u003eIn patients with obstructive disease of the bile ducts and severe hepatic failure.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eCAUTIONS:\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eRenovascular hypertension: Risk of severe hypotension and renal insufficiency when patients with bilateral stenosis of renal artery stenosis or artery of a functioning kidney are treated with drugs affecting the renin-angiotensin-aldosterone system.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eRenal failure and kidney transplantation: MICARDIS * When given to patients with renal insufficiency is recommended continued monitoring of plasma potassium and creatinine. \u003c\/span\u003e\u003cspan title=\"\"\u003eThere is no experience with the drug's use in patients with recent kidney transplant.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eIntravascular volume depletion, can occur manifestations symptomatic hypotension, especially after the first dose administration in patients with volume depletion and \/ or sodium after extensive treatment with diuretics in salt-restricted diets, diarrhea or \u003c\/span\u003e\u003cspan title=\"\"\u003evomiting. \u003c\/span\u003e\u003cspan title=\"\"\u003eThese conditions, especially volume depletion and \/ or sodium should be corrected prior to administration of MICARDIS *.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eOther conditions with stimulation of the renin-angiotensin-aldosterone system: In patients whose vascular tone and renal function depend predominantly on the activity of the renin-angiotensin-aldosterone system (eg patients with severe congestive heart failure or underlying renal disease, \u003c\/span\u003e\u003cspan title=\"\"\u003eincluding renal artery stenosis), treatment with drugs that affect this system has been associated with acute hypotension, azotemia, oliguria, and rarely with acute renal failure.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003ePrimary aldosteronism: patients with primary aldosteronism generally will not respond to antihypertensive treatments that act by inhibiting the renin-angiotensin system, so this medication is not recommended in these cases.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eAortic and mitral stenosis, hypertrophic obstructive cardiomyopathy: As with other vasodilators, special caution is recommended in patients with these diseases.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eHyperkalemia: Hyperkalemia may occur during treatment with drugs that affect the renin-angiotensin-aldosterone system, especially in cases of renal failure and \/ or heart disease. \u003c\/span\u003e\u003cspan title=\"\"\u003eIt is advisable to monitor serum potassium in patients at risk.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eBased on experience with drugs affecting the renin-angiotensin-aldosterone system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other drugs that increase potassium levels \u003c\/span\u003e\u003cspan title=\"\"\u003e(heparin, etc.) can lead to an increase in serum potassium levels, so caution should be exercised when administered simultaneously with MICARDIS *.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eHepatic impairment: The drug is eliminated with the bile. \u003c\/span\u003e\u003cspan title=\"\"\u003eIn patients with obstructive disease of the bile ducts or liver failure is expected to have decreased their disposal. \u003c\/span\u003e\u003cspan title=\"\"\u003eMICARDIS * should be used with caution in these patients.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eSorbitol: A daily dose of 40 mg of MICARDIS *, which contains 169 mg of sorbitol, or 80 mg to 338 mg, are not suitable for patients with hereditary fructose intolerance.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eOther: As with other ACE inhibitors, angiotensin receptor blockers, including MICARDIS *, are apparently less effective in lowering blood pressure in black hypertensive patients, probably due to the high prevalence of stages with concentrations \u003c\/span\u003e\u003cspan title=\"\"\u003elow renin.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eAs with other antihypertensive therapy, excessive lowering of blood pressure in patients with ischemic heart disease can result in a myocardial infarction or cerebral vascular disease (CVD).\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eThere have been no studies on the ability to manage vehicles and equipment, but must take into account that dizziness or drowsiness may occur as a result of antihypertensive therapy.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\" style=\"background-color: rgb(230, 236, 249);\"\u003eRESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: MICARDIS * should not be administered during pregnancy and lactation. \u003c\/span\u003e\u003cspan title=\"\"\u003eWe should make a change to a suitable alternative if you are planning a pregnancy.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eDuring pregnancy, substances that act directly on the renin-angiotensin system can cause injury and even death to product development, therefore, telmisartan is contraindicated during pregnancy.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eIf it is determined during medication pregnancy with telmisartan, the latter should be discontinued immediately.\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\" style=\"font-family: arial; font-size: 12px; zoom: 1;\"\u003e\u003cspan class=\"\" lang=\"en\"\u003e\u003cspan title=\"\"\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv dir=\"ltr\" style=\"font-family: arial; font-size: 12px; zoom: 1;\"\u003e\u003cspan class=\"\" lang=\"en\"\u003e\u003cspan title=\"\"\u003e\u003cspan style=\"color: rgb(51, 51, 51); font-family: arial, sans-serif; font-size: 16px; background-color: rgb(245, 245, 245);\"\u003e\u003cspan class=\"hps\"\u003eDOSAGE AND\u003c\/span\u003e \u003cspan class=\"hps\"\u003eADMINISTRATION:\u003c\/span\u003e \u003cspan class=\"hps\"\u003eOral.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eThe recommended dose\u003c\/span\u003e \u003cspan class=\"hps\"\u003eis 40 to\u003c\/span\u003e \u003cspan class=\"hps\"\u003e80 mg\u003c\/span\u003e \u003cspan class=\"hps\"\u003eonce a\u003c\/span\u003e \u003cspan class=\"hps\"\u003eday.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eSome patients may\u003c\/span\u003e \u003cspan class=\"hps\"\u003ebenefit from\u003c\/span\u003e \u003cspan class=\"hps\"\u003ea dose of 20\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eIn\u003c\/span\u003e \u003cspan class=\"hps\"\u003ecases where\u003c\/span\u003e \u003cspan class=\"hps\"\u003efailure to obtain the\u003c\/span\u003e \u003cspan class=\"hps\"\u003eexpected decline in\u003c\/span\u003e \u003cspan class=\"hps\"\u003eblood pressure,\u003c\/span\u003e \u003cspan class=\"hps\"\u003emay be increased to\u003c\/span\u003e \u003cspan class=\"hps\"\u003e80 mg\u003c\/span\u003e \u003cspan class=\"hps\"\u003ea day.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eWhen considering\u003c\/span\u003e \u003cspan class=\"hps\"\u003ean increase in\u003c\/span\u003e \u003cspan class=\"hps\"\u003edosage should\u003c\/span\u003e \u003cspan class=\"hps\"\u003ebe noted that\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethe maximum antihypertensive effect\u003c\/span\u003e \u003cspan class=\"hps\"\u003eis usually obtained\u003c\/span\u003e \u003cspan class=\"hps\"\u003eafter 4 to\u003c\/span\u003e \u003cspan class=\"hps\"\u003e8 weeks after\u003c\/span\u003e \u003cspan class=\"hps\"\u003estarting treatment.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eIn patients with\u003c\/span\u003e \u003cspan class=\"hps\"\u003esevere hypertension\u003c\/span\u003e \u003cspan class=\"hps\"\u003ehave used\u003c\/span\u003e \u003cspan class=\"hps\"\u003edosages\u003c\/span\u003e \u003cspan class=\"hps\"\u003ehigher than 160\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003ealone or\u003c\/span\u003e \u003cspan class=\"hps\"\u003ein combination\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewith 12.5\u003c\/span\u003e \u003cspan class=\"hps\"\u003eto 25\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003eof hydrochlorothiazide\u003c\/span\u003e \u003cspan class=\"hps\"\u003edaily,\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethey\u003c\/span\u003e \u003cspan class=\"hps\"\u003ehave been\u003c\/span\u003e \u003cspan class=\"hps\"\u003eeffective and well\u003c\/span\u003e\u003cspan class=\"hps\"\u003etolerated.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eNo\u003c\/span\u003e \u003cspan class=\"hps\"\u003edose\u003c\/span\u003e \u003cspan class=\"hps\"\u003eadjustment is necessary\u003c\/span\u003e \u003cspan class=\"hps\"\u003ein patients with\u003c\/span\u003e \u003cspan class=\"hps\"\u003erenal impairment, including\u003c\/span\u003e \u003cspan class=\"hps\"\u003ehemodialysis.\u003c\/span\u003e\u003cspan class=\"hps\"\u003eThe drug is not\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewithdrawn from circulation\u003c\/span\u003e \u003cspan class=\"hps\"\u003eby\u003c\/span\u003e \u003cspan class=\"hps\"\u003ehemofiltration.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eIn patients with\u003c\/span\u003e \u003cspan class=\"hps\"\u003ehepatic impairment\u003c\/span\u003e \u003cspan class=\"hps\"\u003eor moderate\u003c\/span\u003e, the \u003cspan class=\"hps\"\u003emaximum recommended\u003c\/span\u003e \u003cspan class=\"hps\"\u003edaily dose\u003c\/span\u003e \u003cspan class=\"hps\"\u003eis 40\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eIn\u003c\/span\u003e \u003cspan class=\"hps\"\u003eelderly\u003c\/span\u003e \u003cspan class=\"hps\"\u003esubjects\u003c\/span\u003e\u003cspan class=\"hps\"\u003eis not necessary\u003c\/span\u003e \u003cspan class=\"hps\"\u003edosage adjustments\u003c\/span\u003e.\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eNo information\u003c\/span\u003e \u003cspan class=\"hps\"\u003eon the safety\u003c\/span\u003e \u003cspan class=\"hps\"\u003eand efficacy of\u003c\/span\u003e \u003cspan class=\"hps\"\u003eMICARDIS\u003c\/span\u003e \u003cspan class=\"hps\"\u003e*\u003c\/span\u003e \u003cspan class=\"hps\"\u003ein children and\u003c\/span\u003e \u003cspan class=\"hps\"\u003eadolescents.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eMICARDIS\u003c\/span\u003e \u003cspan class=\"hps\"\u003e* can\u003c\/span\u003e \u003cspan class=\"hps\"\u003ebe administered\u003c\/span\u003e \u003cspan class=\"hps\"\u003ebefore or\u003c\/span\u003e \u003cspan class=\"hps\"\u003eafter food\u003c\/span\u003e.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Boehringer","offers":[{"title":"Default Title","offer_id":167616032,"sku":"FDN-00149","price":1688.51,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0111\/7372\/products\/micardis-telmisartan-80mg-28tab.jpg?v=1674145890","url":"https:\/\/www.farmaciasdelnino.com.mx\/products\/micardis-telmisartan-80mg-28tab","provider":"FARMACIA DEL NIÑO","version":"1.0","type":"link"}